EKSO
Ekso Bionics Holdings Inc
NASDAQ: EKSO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$12.01
+4.98% today
Updated 2026-04-30
Market cap
$39.16M
P/E ratio
—
P/S ratio
3.06x
EPS (TTM)
$-4.91
Dividend yield
—
52W range
$3 – $14
Volume
0.1M
Ekso Bionics Holdings Inc (EKSO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11992.00 | $-11992.00 | $-15.01M | $-18.27M | $-25.00M | $-31.23M | $-22.16M | $-15.77M | $-8.76M | $-11.16M | $-14.69M | $-12.05M | $-9.85M | $-11.80M |
| Capital expenditures | $0.00 | $0.00 | $1.49M | $1.49M | $1.10M | $456000.00 | $131000.00 | $60000.00 | $59000.00 | $59000.00 | $194000.00 | $157000.00 | $37000.00 | $188000.00 |
| Depreciation | — | — | $745000.00 | $933000.00 | $1.85M | $1.73M | $1.51M | $690000.00 | $620000.00 | $561000.00 | $887000.00 | $1.70M | $1.61M | — |
| Stock-based comp | — | — | $1.14M | $1.73M | $3.12M | $2.92M | $3.08M | $2.40M | $2.58M | $2.50M | $2.73M | $2.24M | $1.63M | $1.47M |
| Free cash flow | $-11992.00 | $-11992.00 | $-16.49M | $-19.76M | $-26.09M | $-31.68M | $-22.30M | $-15.83M | $-8.81M | $-11.21M | $-14.88M | $-12.21M | $-9.88M | $-11.99M |
| Investing cash flow | — | — | $-1.49M | $-1.49M | $-1.10M | $-456000.00 | $-131000.00 | $-60000.00 | $-59000.00 | $-59000.00 | $-5.17M | $-157000.00 | $-37000.00 | — |
| Financing cash flow | $32724.00 | $32724.00 | $40.88M | $14.12M | $23.31M | $42.57M | $2.27M | $19.04M | $10.70M | $38.71M | $176000.00 | $348000.00 | $7.77M | — |
| Dividends paid | — | — | — | — | $10.35M | — | — | — | — | — | — | — | — | $226000.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $24.39M | $-5.64M | $-2.71M | $10.97M | $-20.16M | — | $1.95M | — | — | — | — | — |